EXTENDED REPORT

¹ Section of Rheumatology, Helsingborgs Lasarett, Helsingborg, Sweden
² Rheumatology Department, Karolinska University Hospital Huddinge, Stockholm, Sweden
³ Rheumatology Department, Sahlgrenska University Hospital/Mölndal, Sweden
⁴ Rheumatology Department, University Hospital, Lund, Sweden

Correspondence to:
Björn Svensson
Blistorpsvägen 546, 290 38 Villands Vånga, Sweden; bjosve{at}telia.com

Background: The treatment goal of early rheumatoid arthritis is remission. This study reports remission rates in clinical practice using a cohort of patients with early rheumatoid arthritis.

Methods: 698 patients with early rheumatoid arthritis were included. Mean age at inclusion was 58 years and mean disease duration was 6.4 months; 64% of the patients were women, 56% were positive for antibodies to cyclic citrullinated peptide and 60% were positive for rheumatoid factor. Remission was defined as a disease activity score <2.6, with or without ongoing treatment with drugs for rheumatoid arthritis.

Results: After 2 years, 261 of 689 patients were in remission (37.9%), and after 5 years, the remission rate was 38.5%. However, only 26.1% were in remission at both these time points. Multiple logistic regression analyses found sex to be a main predictor for remission. Thus, significantly fewer women were in remission after 2 years (32.1% v 48%, p = 0.001) after 5 years (30.8% v 52.4%, p = 0.001) and at both these time points (19.1% v 39.3%, p = 0.001). Although disease activity was not with certainty more pronounced in women at onset of disease, the disease course became markedly worse in women. The disparity in remission frequency between women and men could not be explained by differences in disease duration, age or treatment with disease modifying antirheumatic drugs or glucocorticoids.

Conclusions: Early remission of rheumatoid arthritis by 28-joint Disease Activity Score<2.6 was as frequent or more frequent in this study than in most previous reports. Importantly, women had more severe disease with a considerably lower remission rate than men, although the disease activity before treatment seemed similar.

Abbreviations: anti-CCP, antibodies to cyclic citrullinated peptide; ARA, American Rheumatism Association; BARFOT, Better Anti-Rheumatic FarmacOTherapy; CRP, C reactive protein; DAS28, 28-joint Disease Activity Score; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; SOFI, Signals Of Functional Impairment

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hafstrom, I, Albertsson, K, Boonen, A, van der Heijde, D, Landewe, R, Svensson, B, for the BARFOT Study Group, (2009). Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis 68: 508-513 [Abstract] [Full Text]  
• IIKUNI, N., SATO, E., HOSHI, M., INOUE, E., TANIGUCHI, A., HARA, M., TOMATSU, T., KAMATANI, N., YAMANAKA, H. (2009). The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational Cohort. The Journal of Rheumatology 36: 508-511 [Abstract] [Full Text]  
• MAKINEN, H., HANNONEN, P. (2009). How to Assess Patients with Rheumatoid Arthritis and Concomitant Fibromyalgia?. The Journal of Rheumatology 36: 9-11 [Full Text]  
• Makinen, H, Hannonen, P, Sokka, T (2008). Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis?. Ann Rheum Dis 67: 1052-1053 [Full Text]  
• Haavardsholm, E A, Boyesen, P, Ostergaard, M, Schildvold, A, Kvien, T K (2008). Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 67: 794-800 [Abstract] [Full Text]  
• Kristensen, L. E., Kapetanovic, M. C., Gulfe, A., Soderlin, M., Saxne, T., Geborek, P. (2008). Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 47: 495-499 [Abstract] [Full Text]  
• Syversen, S W, Gaarder, P I, Goll, G L, Odegard, S, Haavardsholm, E A, Mowinckel, P, van der Heijde, D, Landewe, R, Kvien, T K (2008). High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67: 212-217 [Abstract] [Full Text]